OIG Accelerated Approval Report Spotlights Financial Costs Ahead Of Congressional Debate

 
• By Sarah Karlin-Smith
spotlight
New OIG accelerated approval report could impact chances of Congressional reform this year. • Source: Shutterstock

More from US FDA

More from Agency Leadership